Stay updated on Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added the Locations section with a Massachusetts site; removed the HHS Vulnerability Disclosure link and the previous Massachusetts Locations entry, and updated the revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-17T19:51:28.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page adds a note that publications are automatically filled from PubMed and updates the revision from v3.2.0 to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-26T08:35:37.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The deletions remove a government funding lapse notice that stated NIH operations may be affected and directed readers to updates, and the notice is no longer visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-19T08:00:11.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page shows a recent administrative update to Study Record Dates (Last Update Posted 2025-06-19) with no changes to study design, eligibility criteria, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T02:53:16.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    2%
    Check dated 2025-10-06T16:00:37.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T09:53:22.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page.